Market Capitalization & Enterprise Value
Research-grade valuation history for QBIO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Feb 28, 2023EV/EBITDA
-12.40x
Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.
EV vs Market Cap Spread
4.06M
EV is +567.0% vs equity value
Capital Structure Signal
Net Debt Profile
EV premium trend: +567.8 pp vs earliest data
Additional Multiples
EV/Sales: 2145.94x
Net Debt/EBITDA: -9.39x
Share count change in dataset: +795.14%
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Nov 30, 2022 | 716.11K | 4.78M | $0.02 | 44.76M |
| Nov 30, 2021 | 12.11M | 14.82M | $0.45 | 26.78M |
| Nov 30, 2020 | 24.38M | 24.29M | $1.10 | 22.16M |
Nov 30, 2019 | — | — | — | — |
Nov 30, 2018 | — | — | — | — |
Nov 30, 2017 | — | — | — | — |
Nov 30, 2016 | — | — | — | — |
Nov 30, 2015 | — | — | — | — |
Nov 30, 2014 | — | — | — | — |
Nov 30, 2013 | — | — | — | — |

